April 2020 tender notification

Medicines

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2019/20 Invitation to Tender, dated 1 November 2019.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by:

  • For new listings, by 4pm on 12 May 2020 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

PHARMAC cannot list a product (and pharmacies cannot claim) without this information. 

More information about this process and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

Tender results [PDF, 95 KB]

2019/20 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2023

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows: 

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand
(Supplier)

Date of subsidy change

Sole Subsidised Supply date

Ondansetron

Tab disp 4 mg;
10 tablet blister pack

$0.95

$0.76

Ondansetron ODT-DRLA
(Dr Reddy’s)

1 July 2020

1 October 2020

Ondansetron

Tab disp 8 mg;
10 tablet blister pack

$1.43

$1.13

Ondansetron ODT-DRLA
(Dr Reddy’s)

1 July 2020

1 October 2020

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand (Supplier)

Date of listing

Sole Subsidised Supply date

Brand (Supplier) affected by delisting

Bisoprolol fumarate1

Tab 2.5 mg;
90 tablet blister pack

$3.53

$1.84

Bisoprolol Mylan
(Mylan)

1 September 2020

1 February 2021

Bosvate (Douglas)

Bisoprolol fumarate1

Tab 5 mg;
90 tablet bottle pack

$5.15

$2.55

Bisoprolol Mylan
(Mylan)

1 September 2020

1 February 2021

Bosvate (Douglas)

Bisoprolol fumarate1

Tab 10 mg;
90 tablet blister pack

$9.40

$3.62

Bisoprolol Mylan
(Mylan)

1 September 2020

1 February 2021

Bosvate (Douglas)

Darunavir2

Tab 400 mg,
60 tablet bottle pack

$355.00

$132.00

Darunavir Mylan
(Mylan)

1 November 2020

1 April 2021

Prezista (Janssen-Cilag)

Darunavir2

Tab 600 mg,
60 tablet bottle pack

$476.00

$196.55

Darunavir Mylan
(Mylan)

1 November 2020

1 April 2021

Prezista (Janssen-Cilag)

Metronidazole

Tab 200 mg;
250 tablet bottle pack

$36.35

$33.15

Metrogyl

(Mylan)

1 September 2020

1 December 2020

Trichozole (Mylan)
(to be delisted 1 September 2020)

Metronidazole

Tab 400 mg;
21 tablet bottle pack

$5.55

$5.23

Metrogyl

(Mylan)

1 September 2020

1 December 2020

Trichozole (Mylan)
(to be delisted 1 Sepetmeber 2020)

Tobramycin

Solution for inhilation 60 mg per ml, 5 ml;
56 plastic ampoules

$2,200.00

$395.00

Tobramycin BNM
(Boucher)

1 September 2020

1 February 2021

TOBI
(Mylan)

1 Brand switch fee of $4.50 is payable for this product from 1 February 2021 to 30 April 2021

2 Brand switch fee of $4.50 is payable for this product from 1 April 2021 to 30 June 2021

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Hospital supply brand
(Supplier)

DV
Limit

Listing date

Hospital Supply Status date

Clarithromycin

Inj 500 mg vial;

1 vial pack

$12.04

$9.87

Martindale

(Max health)

1%

1 September 2020

1 December 2020

Ondansetron

Tab disp 4 mg;
10 tablet blister pack

$0.95

$0.76

Ondansetron ODT-DRLA
(Dr Reddy’s)

1%

1 July 2020

1 October 2020

Ondansetron

Tab disp 8 mg;
10 tablet blister pack

$1.43

$1.13

Ondansetron ODT-DRLA
(Dr Reddy’s)

1%

1 July 2020

1 October 2020

4. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Hospital supply brand (Supplier)

DV Limit

Listing date

Hospital Supply Status date

Brand (Supplier) affected by delisting

Bisoprolol fumarate

Tab 2.5 mg;
90 tablet blister pack

$3.53

$1.84

Bisoprolol Mylan
(Mylan)

1%

1 September 2020

1 February 2021

Bosvate (Douglas)

Bisoprolol fumarate

Tab 5 mg;
90 tablet bottle pack

$5.15

$2.55

Bisoprolol Mylan
(Mylan)

1%

1 September 2020

1 February 2021

Bosvate (Douglas)

Bisoprolol fumarate

Tab 10 mg;
90 tablet blister pack

$9.40

$3.62

Bisoprolol Mylan
(Mylan)

1%

1 September 2020

1 February 2021

Bosvate (Douglas)

Ceftazidime

Inj 1 g vial;
1 vial pack

$34.00
(per 5)

$2.69 (per 1)

Ceftazidime-AFT
(AFT)

1%

1 July 2020

1 December 2020

Ceftazidime Mylan
(Mylan)

Darunavir

Tab 400 mg,
60  tablet bottle pack

$355.00

$132.00

Darunavir Mylan
(Mylan)

1%

1 November 2020

1 April 2021

Prezista (Janssen-Cilag)

Darunavir

Tab 600 mg,
60 tablet bottle pack

$476.00

$196.55

Darunavir Mylan
(Mylan)

1%

1 November 2020

1 April 2021

Prezista (Janssen-Cilag)

Meropenem

Inj 500 mg vial:
10 vial pack

$4.00
(per 1)

$33.92
(per 10)

Meropenem-AFT
(AFT)

1%

1 November 2020

1 April 2021

Meropenem Ranbaxy
(Douglas)

Meropenem

Inj 1 g vial:
10 vial pack

$8.00
(per 1)

$45.04
 (per 10)

Meropenem-AFT
(AFT)

1%

1 November 2020

1 April 2021

Meropenem Ranbaxy
(Douglas)

Metronidazole

Tab 200 mg;
250 tablet bottle pack

$36.35

$33.15

Metrogyl

(Mylan)

1%

1 September 2020

1 December 2020

Trichozole (Mylan)
(to be delisted 1 September 2020)

Metronidazole

Tab 400 mg;
21 tablet bottle pack

$5.55

$5.23

Metrogyl

(Mylan)

1%

1 September 2020

1 December 2020

Trichozole (Mylan)
(to be delisted 1 September 2020)

Suxamethonium chloride

Inj 50 mg per ml, 2 ml amouple;
10 x 2 ml ampoules

$78.00
(per 50)

$23.40
(per 10)

Martindale
(Max Health)

1%

1 September 2020

1 February 2021

AstraZeneca
(AstraZeneca)

Tobramycin

Solution for inhalation 60 mg per ml, 5 ml;
56 plastic ampoules

$2,200.00

$395.00

Tobramycin BNM
(Boucher)

1%

1 September 2020

1 February 2021

TOBI
(Mylan)

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in: 

2019/20 Invitation to Tender

Chemical name

Line item

Ajmaline

Inj 50 mg per 10 ml

Albendazole

Tab

Amisulpride

Oral liq

Aztreonam

Inj 1 g

Benzoyl peroxide

Soln/Gel/Cream/Lotion 5%

Benzylpenicillin Sodium [Penicillin G]

Inj 3 g

Budesonide

Nebuliser soln, 500 mcg per ml, 2 ml

Budesonide

Nebuliser soln 250 mcg per ml, 2 ml ampoule

Buserelin Acetate

Inj 1 mg per ml, 5.5 ml

Carmellose sodium

Paste

Carmellose sodium

Powder

Carmellose sodium

Eye drops 0.5%

Chloramphenicol

Inj 1 g

Chlorpheniramine Maleate

Oral liq 2 mg per 5 ml

Chlorpheniramine Maleate

Inj 10 mg per ml

Choline salicylate

Oral gel

Diazoxide

Cap 100 mg

Diazoxide

Cap 25 mg

Diazoxide

Oral liq 50 mg per ml

Diazoxide

Inj 15 mg per ml, 20 ml

Diclofenac sodium

Suppos 12.5 mg

Diclofenac sodium

Suppos 25 mg

Diclofenac sodium

Suppos 50 mg

Diclofenac sodium

Suppos 100 mg

Dorzolamide hydrochloride

Eye drops 2%

Epoprostenol (current access)

Inj 1.5 mg vial

Epoprostenol (current access)

Inj 500 mcg vial

Epoprostenol (widened access)

Inj 1.5 mg vial

Epoprostenol (widened access)

Inj 500 mcg vial

Etoposide

Inj 20 mg per ml, 5 ml

Etoposide phosphate

Inj 100 mg (of etoposide base)

Famotidine

Tab 20 mg

Famotidine

Tab 40 mg

Famotidine

Inj

Gentamicin Sulphate

Inj 40 mg per ml, 2 ml

Gentamicin Sulphate

Inj 10 mg per ml

Hydrocortisone butyrate

Cream/lipocream 0.1% (pack size 30 g or less)

Hydrogen peroxide

Soln 3% (10 vol)

Hydrogen Peroxide

Crm 1%

Hypromellose

Eye drops 0.5%

Hypromellose

Eye drops 0.3%

Insulin syringes, disposable with attached needle

Syringe 0.3 ml with 29 g x 4 mm needle

Insulin syringes, disposable with attached needle

Syringe 0.5 ml with 29 g x 4 mm needle

Insulin syringes, disposable with attached needle

Syringe 1 ml with 29 g x 4 mm needle

Levofloxacin

Tab 500 mg

Magnesium

Cap/Tab (150 mg elemental)

Mebendazole

Tab 100 mg

Mitomycin C

Inj 10 mg - 20 mg

Mitomycin C

Inj 2 mg - 5 mg

Morphine

Inj 10 mg per ml, 100 mg cassette

Mucilaginous Laxatives

Dry

Nifedipine

Tab long-acting 10 mg

Nifedipine

Tab long-acting 20 mg

Nifedipine

Tab long-acting 30 mg

Nifedipine

Tab long-acting 60 mg

Oxybutynin

Tab 5 mg

Oxybutynin

Oral liq 1 mg per ml

Pamidronate disodium

Inj 3 mg per ml, 10 ml

Pamidronate disodium

Inj 6 mg per ml, 10 ml

Pamidronate disodium

Inj 9 mg per ml, 10 ml

Phentolamine Mesylate

Inj 10 mg per ml, 1 ml

Phentolamine mesylate

Inj 5 mg per ml, 1 ml

Pivmecillinam

Tab 200 mg

Podophyllotoxin

Soln 0.5%

Poractant Alfa

Soln 120 mg per 1.5 ml vial

Prazosin Hydrochloride

Tab 1 mg

Prazosin Hydrochloride

Tab 2 mg

Prazosin Hydrochloride

Tab 5 mg

Primaquine phosphate

Tab 7.5 - 15 mg

Propafenone hydrochloride

Tab 150 mg

Ranitidine hydrochloride

Oral liq 150 mg per 10 ml

Ranitidine hydrochloride

Tab 150 mg

Ranitidine hydrochloride

Tab 300 mg

Ranitidine hydrochloride

Inj

Risperidone

Inj 25 mg vial

Risperidone

Inj 37.5 mg vial

Risperidone

Inj 50 mg vial

Ropivacaine hydrochloride

Inj 1 mg per ml, 100 ml bag

Ropivacaine hydrochloride

Inj 1 mg per ml, 200 ml bag

Ropivacaine hydrochloride with fentanyl

Inj 2 mg with fentanyl 2 mcg per ml, 100 ml bag

Ropivacaine hydrochloride with fentanyl

Inj 2 mg with fentanyl 2 mcg per ml, 200 ml bag

Ropivacaine hydrochloride with fentanyl

Inj 1 mg with fentanyl 2 mcg per ml, 100 ml bag

Ropivacaine hydrochloride with fentanyl

Inj 1 mg with fentanyl 2 mcg per ml, 200 ml bag

Salicylic Acid

Powder

Sodium fusidate [fusidic acid]

Eye drops 1%

Tetracycline

Tab 250 mg

Tetracycline

Cap 500 mg

Thiamine Hydrochloride

Tab 100 mg

Thiamine Hydrochloride

Inj 100 mg per ml, 2 ml

Thiamine hydrochloride

Inj 100 mg per ml, 1 ml

Tolterodone tartrate

Tab 1 mg

Tolterodone tartrate

Tab 2 mg

Triclosan

Soln 1%

Valganciclovir

Oral liq

Verapamil hydrochloride

Inj 2.5 mg per ml, 2 ml

Verapamil hydrochloride

Tab 40 mg

Verapamil hydrochloride

Tab 80 mg

Yellow jacket wasp venom

Inj with diluent for extract

Yellow jacket wasp venom

Treatment kit

2018/19 Invitation to Tender

Chemical name

Line item

Octreotide (somatostatin analogue)

LAR 10 mg pre-filled syringe

Octreotide (somatostatin analogue)

LAR 20 mg pre-filled syringe

Octreotide (somatostatin analogue)

LAR 30 mg pre-filled syringe

For products included in the 2017/18 and 2018/19 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.

 

##Date##
2020-04-30

##Leader##

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2019/20 Invitation to Tender, dated 1 November 2019.

 

##RelatedInfo##

##Author##
Kim Ellis